Listen Presentations & Publications Share Facebook Linkedin Twitter Whatsapp Email Axiomer technology Axiomer RNA editing technology Internal link TIDES Europe (2022) Gerard Platenburg, Progress on Development of RNA Base Editing Technologies for Precision Medicines Internal link TIDES USA (2022) Gerard Platenburg, Development of RNA Base Editing Technologies for Precision Medicines Download link Axiomer Technology Overview pdf, 2.25 MB Internal link JACS (2021) Erin E. Doherty et al., Rational Design of RNA Editing Guide Strands: Cytidine Analogs at the Orphan Position Internal link OTS (2018) Julien Boudet et al., Structure-based computational approach for optimizing oligonucleotides for A-to-I editing Internal link TIDES EU (2018) Antti Aalto, Axiomer Technology - Therapeutic oligonucleotides for directing site-specific A-to-I editing by endogenous ADAR enzymes Share page Facebook Linkedin Twitter Whatsapp Email You might like this RNA science Our antisense oligonucleotides are designed to correct mutations in a person’s RNA. This highly precise approach aims to stop disease progression or even reverse symptoms. Working at ProQR - Careers We are an innovative biotech company headquartered in Leiden, the Netherlands. We focus on the development of life-changing RNA therapies for severe rare and common diseases. Are you up for a challenge? Press releases Read the latest news on our development programs, business updates and announcements. You can sign up for email alerts so you stay up to date on all things ProQR.